XDH and gout: Emphasizing the necessity for enhanced treatment options, particularly for individuals with concurrent health issues, the study examines the roles of xanthine oxidase inhibitors (allopurinol, febuxostat) and uricosuric agents (lesinurad) in optimizing outcomes for acute gout patients.